Actively Recruiting

Phase 4
Age: 18Years - 75Years
All Genders
NCT05126147

Hydroxychloroquine in Mild Graves' Orbitopathy

Led by National Taiwan University Hospital · Updated on 2025-02-25

108

Participants Needed

2

Research Sites

249 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is aimed to investigate the effect of hydroxychloroquine in patients with mild Graves' orbitopathy (GO).

CONDITIONS

Official Title

Hydroxychloroquine in Mild Graves' Orbitopathy

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of mild Graves' orbitopathy according to European Group on Graves' orbitopathy (EUGOGO) guidelines by endocrinologist and ophthalmologist
  • No previous treatment for Graves' orbitopathy except eyedrops
  • Euthyroidism with normalized free T4 and TSH for at least 2 months, or at least 6 months if radioactive iodine was used for hyperthyroidism
Not Eligible

You will not qualify if you...

  • Moderate-to-severe or sight-threatening Graves' orbitopathy according to EUGOGO guidelines diagnosed by endocrinologist and ophthalmologist
  • Pregnancy
  • Drug or alcohol abuse
  • Unable to comply with the study protocol or provide informed consent
  • Use of hydroxychloroquine or systemic steroids within 3 months prior to enrollment
  • History of hydroxychloroquine side effects or retinopathy
  • Kidney dysfunction (eGFR < 60 ml/min)
  • Liver dysfunction (AST or ALT more than twice the upper limit)
  • Anemia (hemoglobin less than 10 g/dl)
  • Neutropenia (absolute neutrophil count less than 100/uL)
  • Thrombocytopenia (platelet count less than 150,000/uL)
  • Glucose-6-phosphate dehydrogenase deficiency
  • Porphyria cutanea tarda
  • Allergy to 4-aminoquinoline drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

National Taiwan University Hospital, Hsin-Chu branch

Hsinchu, Taiwan

Actively Recruiting

2

National Taiwan University Hospital

Taipei, Taiwan

Actively Recruiting

Loading map...

Research Team

S

Shyang-Rong Shih

CONTACT

H

Hung-Yuan Li

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here